
Oncology NEWS International
- Oncology NEWS International Vol 7 No 8
- Volume 7
- Issue 8
Henney Nominated for FDA Commissioner
WASHINGTON--President Clinton has nominated Jane E. Henney, MD, vice president for health sciences, University of New Mexico, as the new FDA Commissioner. She would replace David M. Kessler, MD, who resigned more than a year ago and is now dean of the Yale University School of Medicine.
WASHINGTON--President Clinton has nominated Jane E. Henney, MD, vice president for health sciences, University of New Mexico, as the new FDA Commissioner. She would replace David M. Kessler, MD, who resigned more than a year ago and is now dean of the Yale University School of Medicine.
Dr. Henney, a cancer specialist, has served in government under every president since Jimmy Carter. She was the FDAs deputy commissioner for operations from 1992 to 1994.
Her nomination won warm praise from many in the medical and public health fields, including Health and Human Services Secretary Donna E. Shalala, PhD. The Secretary called Dr. Henney "a talented manager" with "the solid medical and academic credentials that are needed to understand the burgeoning field of biomedical research."
However, several conservative Republicans have indicated their opposition to Dr. Henney. They want to know specifically if she had anything to do with the FDAs decision to allow testing of the abortion drug RU-486.
Articles in this issue
almost 28 years ago
Taxol, Gemzar, Other Therapies Studied in Metastatic Bladder Canceralmost 28 years ago
Medicare+Choice Opens Certificationalmost 28 years ago
Consumer Advocates Win a Voice in NCI Programsalmost 28 years ago
Paclitaxel Shows Antiangiogenesis Effects in Mouse Modelalmost 28 years ago
FDA Approves ImageChecker Computer Systemalmost 28 years ago
Pittsburgh Seeks Breast Cancer Patients for Study on Copingalmost 28 years ago
Octreotide Imaging Improves Staging of Hodgkin’s Diseasealmost 28 years ago
Tobacco Contributions Are Linked to Votes Against Tobacco Billalmost 28 years ago
Kaposi’s Sarcoma, Cervical Dysplasia Both Improve With Anti-HIV Therapyalmost 28 years ago
Long-Term Treatment Issues Surface at AIDS MeetingNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content



















































